Myomo, Inc. (AMEX: MYO) Stock Competitors & Peer Comparison
See MYO's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MYO and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MYO | $1.61 | -3.59% | 61.8M | -4.85 | -$0.33 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $101.29 | +0.22% | 175.3B | 19.44 | $5.21 | +2.45% |
| MDT | $88.64 | +0.15% | 113.5B | 16.03 | $5.53 | +3.24% |
| SYK | $272.36 | +0.97% | 104.5B | 20.35 | $13.39 | +1.28% |
| BSX | $43.92 | -1.70% | 65.3B | 14.17 | $3.10 | N/A |
| EW | $86.29 | +0.65% | 49.7B | 31.96 | $2.70 | N/A |
| DXCM | $86.62 | -0.97% | 32.7B | 33.97 | $2.55 | N/A |
| GEHC | $66.63 | +0.38% | 30.1B | 14.61 | $4.56 | +0.21% |
| PHG | $24.96 | +1.67% | 24.4B | 14.26 | $1.75 | +3.97% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
MYO vs BSX-PA Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, MYO's ROE is -1.42%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, MYO is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
MYO vs ABT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ABT trades at $101.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ABT's P/E ratio is 19.44. In terms of profitability, MYO's ROE is -1.42%, compared to ABT's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ABT's competition here
Medtronic plc (NYSE: MDT)
MYO vs MDT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, MDT has a market cap of 113.5B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while MDT trades at $88.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas MDT's P/E ratio is 16.03. In terms of profitability, MYO's ROE is -1.42%, compared to MDT's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
MYO vs SYK Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SYK has a market cap of 104.5B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SYK trades at $272.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SYK's P/E ratio is 20.35. In terms of profitability, MYO's ROE is -1.42%, compared to SYK's ROE of +0.16%. Regarding short-term risk, MYO is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
MYO vs BSX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BSX has a market cap of 65.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BSX trades at $43.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BSX's P/E ratio is 14.17. In terms of profitability, MYO's ROE is -1.42%, compared to BSX's ROE of +0.15%. Regarding short-term risk, MYO is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
MYO vs EW Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, EW has a market cap of 49.7B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while EW trades at $86.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas EW's P/E ratio is 31.96. In terms of profitability, MYO's ROE is -1.42%, compared to EW's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for MYO.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
MYO vs DXCM Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while DXCM trades at $86.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas DXCM's P/E ratio is 33.97. In terms of profitability, MYO's ROE is -1.42%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, MYO is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for MYO.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
MYO vs GEHC Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, GEHC has a market cap of 30.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while GEHC trades at $66.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas GEHC's P/E ratio is 14.61. In terms of profitability, MYO's ROE is -1.42%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, MYO is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for MYO.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
MYO vs PHG Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, PHG has a market cap of 24.4B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while PHG trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas PHG's P/E ratio is 14.26. In terms of profitability, MYO's ROE is -1.42%, compared to PHG's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for MYO.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
MYO vs ZBH Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ZBH trades at $91.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ZBH's P/E ratio is 10.73. In terms of profitability, MYO's ROE is -1.42%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, MYO is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
MYO vs ABMD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ABMD's P/E ratio is 65.36. In terms of profitability, MYO's ROE is -1.42%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
MYO vs SWAV Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SWAV's P/E ratio is 78.76. In terms of profitability, MYO's ROE is -1.42%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, MYO is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
MYO vs PEN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while PEN trades at $318.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas PEN's P/E ratio is 83.25. In terms of profitability, MYO's ROE is -1.42%, compared to PEN's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
MYO vs SNN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SNN trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SNN's P/E ratio is 18.17. In terms of profitability, MYO's ROE is -1.42%, compared to SNN's ROE of +0.12%. Regarding short-term risk, MYO is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
MYO vs BIO-B Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, MYO's ROE is -1.42%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, MYO is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
MYO vs ALGN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ALGN has a market cap of 10.5B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ALGN trades at $146.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ALGN's P/E ratio is 13.38. In terms of profitability, MYO's ROE is -1.42%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
MYO vs BIO Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BIO has a market cap of 10.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BIO trades at $381.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BIO's P/E ratio is 41.05. In terms of profitability, MYO's ROE is -1.42%, compared to BIO's ROE of +0.03%. Regarding short-term risk, MYO is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
MYO vs GMED Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while GMED trades at $74.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas GMED's P/E ratio is 16.79. In terms of profitability, MYO's ROE is -1.42%, compared to GMED's ROE of +0.12%. Regarding short-term risk, MYO is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for MYO.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
MYO vs BRKR Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BRKR trades at $64.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BRKR's P/E ratio is 32.25. In terms of profitability, MYO's ROE is -1.42%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, MYO is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
MYO vs BRKRP Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BRKRP has a market cap of 9.4B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BRKRP trades at $470.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BRKRP's P/E ratio is 255.66. In terms of profitability, MYO's ROE is -1.42%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, MYO is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BRKRP's competition here
Insulet Corp. (NASDAQ: PODD)
MYO vs PODD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, PODD has a market cap of 9.4B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while PODD trades at $136.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas PODD's P/E ratio is 23.19. In terms of profitability, MYO's ROE is -1.42%, compared to PODD's ROE of +0.27%. Regarding short-term risk, MYO is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
MYO vs MASI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas MASI's P/E ratio is 44.43. In terms of profitability, MYO's ROE is -1.42%, compared to MASI's ROE of +0.09%. Regarding short-term risk, MYO is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for MYO.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
MYO vs GKOS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while GKOS trades at $154.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas GKOS's P/E ratio is -180.02. In terms of profitability, MYO's ROE is -1.42%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, MYO is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for MYO.Check GKOS's competition here
Haemonetics Corporation (NYSE: HAE)
MYO vs HAE Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while HAE trades at $105.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas HAE's P/E ratio is 21.02. In terms of profitability, MYO's ROE is -1.42%, compared to HAE's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for MYO.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
MYO vs NARI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas NARI's P/E ratio is -59.24. In terms of profitability, MYO's ROE is -1.42%, compared to NARI's ROE of -0.00%. Regarding short-term risk, MYO is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for MYO.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
MYO vs ITGR Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ITGR's P/E ratio is 19.89. In terms of profitability, MYO's ROE is -1.42%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, MYO is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
MYO vs LIVN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while LIVN trades at $76.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas LIVN's P/E ratio is 18.20. In terms of profitability, MYO's ROE is -1.42%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, MYO is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
MYO vs AXNX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas AXNX's P/E ratio is -709.80. In terms of profitability, MYO's ROE is -1.42%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, MYO is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
MYO vs IRTC Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while IRTC trades at $110.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas IRTC's P/E ratio is -256.70. In terms of profitability, MYO's ROE is -1.42%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, MYO is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for MYO.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
MYO vs NEOG Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while NEOG trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas NEOG's P/E ratio is 49.14. In terms of profitability, MYO's ROE is -1.42%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, MYO is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for MYO.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
MYO vs TMDX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while TMDX trades at $85.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas TMDX's P/E ratio is 43.29. In terms of profitability, MYO's ROE is -1.42%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, MYO is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check TMDX's competition here
Butterfly Network, Inc. (NYSE: BFLY)
MYO vs BFLY Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BFLY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BFLY's P/E ratio is -39.13. In terms of profitability, MYO's ROE is -1.42%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, MYO is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
MYO vs AXGN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while AXGN trades at $43.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas AXGN's P/E ratio is 114.18. In terms of profitability, MYO's ROE is -1.42%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, MYO is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
MYO vs UFPT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while UFPT trades at $295.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas UFPT's P/E ratio is 30.20. In terms of profitability, MYO's ROE is -1.42%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, MYO is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
MYO vs NUVA Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas NUVA's P/E ratio is 75.00. In terms of profitability, MYO's ROE is -1.42%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, MYO is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for MYO.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
MYO vs INSP Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while INSP trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas INSP's P/E ratio is 31.06. In terms of profitability, MYO's ROE is -1.42%, compared to INSP's ROE of +0.18%. Regarding short-term risk, MYO is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for MYO.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
MYO vs ESTA Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ESTA trades at $65.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ESTA's P/E ratio is -52.36. In terms of profitability, MYO's ROE is -1.42%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, MYO is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
MYO vs NVCR Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while NVCR trades at $15.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas NVCR's P/E ratio is -12.18. In terms of profitability, MYO's ROE is -1.42%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, MYO is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for MYO.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
MYO vs ATEC Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ATEC trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ATEC's P/E ratio is -168.67. In terms of profitability, MYO's ROE is -1.42%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, MYO is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
MYO vs CNMD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CNMD trades at $45.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CNMD's P/E ratio is 9.97. In terms of profitability, MYO's ROE is -1.42%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, MYO is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
MYO vs HSKA Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas HSKA's P/E ratio is -62.49. In terms of profitability, MYO's ROE is -1.42%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, MYO is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for MYO.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
MYO vs IART Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while IART trades at $16.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas IART's P/E ratio is 6.83. In terms of profitability, MYO's ROE is -1.42%, compared to IART's ROE of -0.01%. Regarding short-term risk, MYO is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for MYO.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
MYO vs AVNS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas AVNS's P/E ratio is 27.77. In terms of profitability, MYO's ROE is -1.42%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, MYO is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for MYO.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
MYO vs SILK Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SILK's P/E ratio is -18.96. In terms of profitability, MYO's ROE is -1.42%, compared to SILK's ROE of -0.35%. Regarding short-term risk, MYO is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
MYO vs AORT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while AORT trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas AORT's P/E ratio is 37.75. In terms of profitability, MYO's ROE is -1.42%, compared to AORT's ROE of -0.01%. Regarding short-term risk, MYO is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check AORT's competition here
Paragon 28, Inc. (NYSE: FNA)
MYO vs FNA Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas FNA's P/E ratio is -19.83. In terms of profitability, MYO's ROE is -1.42%, compared to FNA's ROE of -0.35%. Regarding short-term risk, MYO is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for MYO.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
MYO vs IRMD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while IRMD trades at $85.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas IRMD's P/E ratio is 43.10. In terms of profitability, MYO's ROE is -1.42%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, MYO is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
MYO vs TNDM Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while TNDM trades at $15.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas TNDM's P/E ratio is -16.90. In terms of profitability, MYO's ROE is -1.42%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, MYO is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for MYO.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
MYO vs ENOV Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ENOV trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ENOV's P/E ratio is 5.29. In terms of profitability, MYO's ROE is -1.42%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, MYO is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
MYO vs LMRI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, LMRI has a market cap of 981M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while LMRI trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas LMRI's P/E ratio is -19.86. In terms of profitability, MYO's ROE is -1.42%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, MYO is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for MYO.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
MYO vs PRCT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, PRCT has a market cap of 979M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while PRCT trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas PRCT's P/E ratio is -8.87. In terms of profitability, MYO's ROE is -1.42%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, MYO is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
MYO vs BBNX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BBNX has a market cap of 967.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BBNX trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BBNX's P/E ratio is -13.04. In terms of profitability, MYO's ROE is -1.42%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, MYO is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BBNX's competition here
Bioventus Inc. (NASDAQ: BVS)
MYO vs BVS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BVS has a market cap of 935.6M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BVS trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BVS's P/E ratio is 18.17. In terms of profitability, MYO's ROE is -1.42%, compared to BVS's ROE of +0.28%. Regarding short-term risk, MYO is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for MYO.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
MYO vs CBLL Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CBLL has a market cap of 898.9M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CBLL trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CBLL's P/E ratio is -13.46. In terms of profitability, MYO's ROE is -1.42%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, MYO is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
MYO vs CSII Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CSII's P/E ratio is -20.83. In terms of profitability, MYO's ROE is -1.42%, compared to CSII's ROE of -0.14%. Regarding short-term risk, MYO is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
MYO vs SIBN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SIBN has a market cap of 824.5M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SIBN trades at $18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SIBN's P/E ratio is -54.68. In terms of profitability, MYO's ROE is -1.42%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, MYO is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
MYO vs INMD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, INMD has a market cap of 819.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while INMD trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas INMD's P/E ratio is 9.90. In terms of profitability, MYO's ROE is -1.42%, compared to INMD's ROE of +0.12%. Regarding short-term risk, MYO is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
MYO vs VREX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas VREX's P/E ratio is 19.42. In terms of profitability, MYO's ROE is -1.42%, compared to VREX's ROE of +0.05%. Regarding short-term risk, MYO is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
MYO vs AHCO Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, AHCO has a market cap of 767.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while AHCO trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas AHCO's P/E ratio is 11.51. In terms of profitability, MYO's ROE is -1.42%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, MYO is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for MYO.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
MYO vs AVR Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, AVR has a market cap of 747.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while AVR trades at $7.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas AVR's P/E ratio is -3.96. In terms of profitability, MYO's ROE is -1.42%, compared to AVR's ROE of -0.78%. Regarding short-term risk, MYO is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for MYO.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
MYO vs CTKB Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CTKB has a market cap of 729.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CTKB trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CTKB's P/E ratio is -29.93. In terms of profitability, MYO's ROE is -1.42%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, MYO is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
MYO vs SRDX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SRDX's P/E ratio is -34.66. In terms of profitability, MYO's ROE is -1.42%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, MYO is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SRDX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
MYO vs SSII Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SSII has a market cap of 590.4M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SSII trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SSII's P/E ratio is -49.17. In terms of profitability, MYO's ROE is -1.42%, compared to SSII's ROE of -0.27%. Regarding short-term risk, MYO is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SSII's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
MYO vs APEN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas APEN's P/E ratio is -9.43. In terms of profitability, MYO's ROE is -1.42%, compared to APEN's ROE of -0.85%. Regarding short-term risk, MYO is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
MYO vs KIDS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, KIDS has a market cap of 579.2M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while KIDS trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas KIDS's P/E ratio is -19.11. In terms of profitability, MYO's ROE is -1.42%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, MYO is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for MYO.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
MYO vs DCTH Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, DCTH has a market cap of 538.5M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while DCTH trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas DCTH's P/E ratio is 1560.00. In terms of profitability, MYO's ROE is -1.42%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, MYO is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for MYO.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
MYO vs ZIMV Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, MYO's ROE is -1.42%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, MYO is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
MYO vs CERS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CERS has a market cap of 528M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CERS trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CERS's P/E ratio is -87.04. In terms of profitability, MYO's ROE is -1.42%, compared to CERS's ROE of -0.10%. Regarding short-term risk, MYO is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
MYO vs TCMD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, TCMD has a market cap of 512.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while TCMD trades at $22.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas TCMD's P/E ratio is 21.05. In terms of profitability, MYO's ROE is -1.42%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check TCMD's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
MYO vs PACB Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, PACB has a market cap of 503.2M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while PACB trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas PACB's P/E ratio is -3.95. In terms of profitability, MYO's ROE is -1.42%, compared to PACB's ROE of -49.62%. Regarding short-term risk, MYO is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for MYO.Check PACB's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
MYO vs SGHT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SGHT has a market cap of 485.9M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SGHT trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SGHT's P/E ratio is -15.95. In terms of profitability, MYO's ROE is -1.42%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, MYO is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SGHT's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
MYO vs NPCE Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, NPCE has a market cap of 479.4M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while NPCE trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas NPCE's P/E ratio is -24.67. In terms of profitability, MYO's ROE is -1.42%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, MYO is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for MYO.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
MYO vs CLPT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CLPT has a market cap of 444.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CLPT trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CLPT's P/E ratio is -12.57. In terms of profitability, MYO's ROE is -1.42%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, MYO is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
MYO vs SENS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SENS has a market cap of 417.9M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SENS trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SENS's P/E ratio is -4.48. In terms of profitability, MYO's ROE is -1.42%, compared to SENS's ROE of -1.66%. Regarding short-term risk, MYO is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
MYO vs OFIX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, OFIX has a market cap of 381.6M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while OFIX trades at $9.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas OFIX's P/E ratio is -6.15. In terms of profitability, MYO's ROE is -1.42%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, MYO is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for MYO.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
MYO vs CV Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CV has a market cap of 332.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CV trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CV's P/E ratio is -10.56. In terms of profitability, MYO's ROE is -1.42%, compared to CV's ROE of -1.78%. Regarding short-term risk, MYO is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for MYO.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
MYO vs SMLR Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas SMLR's P/E ratio is 3.92. In terms of profitability, MYO's ROE is -1.42%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, MYO is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for MYO.Check SMLR's competition here
Avita Medical Inc. (NASDAQ: RCEL)
MYO vs RCEL Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, RCEL has a market cap of 294.1M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while RCEL trades at $11.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas RCEL's P/E ratio is -8.22. In terms of profitability, MYO's ROE is -1.42%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, MYO is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for MYO.Check RCEL's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
MYO vs TMCI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, TMCI has a market cap of 291.9M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while TMCI trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas TMCI's P/E ratio is -4.79. In terms of profitability, MYO's ROE is -1.42%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, MYO is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for MYO.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
MYO vs CATX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, CATX has a market cap of 286.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while CATX trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas CATX's P/E ratio is -1.89. In terms of profitability, MYO's ROE is -1.42%, compared to CATX's ROE of -0.42%. Regarding short-term risk, MYO is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
MYO vs TLSI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, TLSI has a market cap of 267.2M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while TLSI trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas TLSI's P/E ratio is -2.58. In terms of profitability, MYO's ROE is -1.42%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, MYO is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for MYO.Check TLSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MYO vs INFU Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, INFU has a market cap of 257.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while INFU trades at $12.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas INFU's P/E ratio is 31.10. In terms of profitability, MYO's ROE is -1.42%, compared to INFU's ROE of +0.15%. Regarding short-term risk, MYO is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for MYO.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
MYO vs MGRM Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas MGRM's P/E ratio is -12.00. In terms of profitability, MYO's ROE is -1.42%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, MYO is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for MYO.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
MYO vs ELMD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ELMD has a market cap of 231.4M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ELMD trades at $27.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ELMD's P/E ratio is 21.34. In terms of profitability, MYO's ROE is -1.42%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, MYO is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
MYO vs NVRO Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas NVRO's P/E ratio is -1.91. In terms of profitability, MYO's ROE is -1.42%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, MYO is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for MYO.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
MYO vs PROF Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, PROF has a market cap of 209.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while PROF trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas PROF's P/E ratio is -5.88. In terms of profitability, MYO's ROE is -1.42%, compared to PROF's ROE of -0.56%. Regarding short-term risk, MYO is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for MYO.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
MYO vs RXST Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, RXST has a market cap of 192.9M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while RXST trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas RXST's P/E ratio is -4.12. In terms of profitability, MYO's ROE is -1.42%, compared to RXST's ROE of -0.17%. Regarding short-term risk, MYO is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for MYO.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
MYO vs BSGM Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas BSGM's P/E ratio is -5.81. In terms of profitability, MYO's ROE is -1.42%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, MYO is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for MYO.Check BSGM's competition here
Neuronetics, Inc. (NASDAQ: STIM)
MYO vs STIM Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, STIM has a market cap of 190.7M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while STIM trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas STIM's P/E ratio is -6.23. In terms of profitability, MYO's ROE is -1.42%, compared to STIM's ROE of -1.51%. Regarding short-term risk, MYO is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for MYO.Check STIM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
MYO vs MDGS Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas MDGS's P/E ratio is -0.27. In terms of profitability, MYO's ROE is -1.42%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, MYO is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for MYO.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
MYO vs FOCL Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, FOCL has a market cap of 176.5M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while FOCL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas FOCL's P/E ratio is -4.55. In terms of profitability, MYO's ROE is -1.42%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, MYO is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for MYO.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
MYO vs QSI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, QSI has a market cap of 165M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while QSI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas QSI's P/E ratio is -1.81. In terms of profitability, MYO's ROE is -1.42%, compared to QSI's ROE of -0.47%. Regarding short-term risk, MYO is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for MYO.Check QSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
MYO vs QIPT Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas QIPT's P/E ratio is -15.87. In terms of profitability, MYO's ROE is -1.42%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, MYO is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for MYO.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
MYO vs LUCD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, LUCD has a market cap of 157.6M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while LUCD trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas LUCD's P/E ratio is -2.23. In terms of profitability, MYO's ROE is -1.42%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, MYO is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check LUCD's competition here
Quanterix Corporation (NASDAQ: QTRX)
MYO vs QTRX Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, QTRX has a market cap of 154M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while QTRX trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas QTRX's P/E ratio is -1.29. In terms of profitability, MYO's ROE is -1.42%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, MYO is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for MYO.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
MYO vs INGN Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, INGN has a market cap of 145.1M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while INGN trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas INGN's P/E ratio is -5.89. In terms of profitability, MYO's ROE is -1.42%, compared to INGN's ROE of -0.13%. Regarding short-term risk, MYO is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for MYO.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
MYO vs ICAD Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ICAD's P/E ratio is -20.37. In terms of profitability, MYO's ROE is -1.42%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, MYO is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
MYO vs ECOR Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, ECOR has a market cap of 100.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while ECOR trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas ECOR's P/E ratio is -6.62. In terms of profitability, MYO's ROE is -1.42%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, MYO is more volatile compared to ECOR. This indicates higher risk in terms of short-term price fluctuations for MYO.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
MYO vs HJLI Comparison September 2026
Myomo, Inc. (AMEX: MYO) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 61.8M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, MYO is priced at $1.61 on the AMEX, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -4.85, whereas HJLI's P/E ratio is N/A. In terms of profitability, MYO's ROE is -1.42%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, MYO is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for MYO.Check HJLI's competition here